Roxin Ghana Limited Pharmaceutical Import Profile — Ghana (DGFT 2022–2026)

Name: Roxin Ghana Limited Pharmaceutical Import Records from India — 3 Products, $5.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Roxin Ghana Limited — Pharmaceutical Importer Profile (2026) | 3 Products, $5.5M Trade | TransData Nexus

Roxin Ghana Limited

Pharmaceutical Importer · Ghana · Respiratory & OTC Focus · $5.5M Total Trade · DGFT Verified

Roxin Ghana Limited is a pharmaceutical importer based in Ghana with a total trade value of $5.5M across 3 products in 3 therapeutic categories. Based on 439 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Roxin Ghana Limited sources from 2 verified Indian suppliers, with Ronak Exim Private Limited accounting for 98.0% of imports.

Roxin Ghana Limited — Import Portfolio & Supplier Network

Roxin Ghana Limited import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Roxin Ghana Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Ronak Exim Private Limited	$15.6M	1,643	98.0%
Aculife Healthcare Private Limited	$321.5K	64	2.0%

Roxin Ghana Limited sources from 2 verified Indian suppliers across .

What Formulations Does Roxin Ghana Limited Import?

Formulation	Value	Ships
Ronfit forte (Pack size : 10 x 2 x10)(paracetamol BP 500MG, diclofenac sodium BP 50MG, caffeine (anhydrous)	$463.1K	14
Human pharmaceutical formulations -	$357.9K	26
Human pharmaceutical formulations - ronfit forte capsules paracetamol BP 500 MG diclofenac sodium BP 50 MG	$258.3K	8
Ronfit forte Pack size 10 x 2 x10 paracetamol BP 500MG diclofenac sodium BP 50MG caffeine	$139.7K	5
Redsun jelly (Pack size : 10 x 4 sachets)(sildenafil citrate oral jelly 100 MG)	$127.8K	6
Ronfit forte (Pack size 10 x 2 x 10)(paracetamol BP 500MG, diclofenac sodium BP 50MG, caffeine (anhydrous) BP 30 MG)	$126.7K	9
Ronfit forte (Pack size : 10 x 2 x10) (paracetamol BP 500MG, diclofenac sodium BP 50MG, caffeine (anhydrous)	$125.5K	4
Ronatril forte (Pack size : 10 x 2x 10)(Each hard gelatin capsule contains: paracetamol BP 500MG	$122.9K	6
Ronsons forte (Pack size : 10 x 10)(Each uncoated tablet contains: paracetamol BP 500 MG, diclofenac sodium	$116.5K	3
Ronfit forte (Pack size 10 x 2 x 10 )(paracetamol BP 500 MG diclofenac sodiumbp 50 mgcaffeine (anhydrous) BP 30 MG	$100.7K	3
Human pharmaceutical formulations -	$100.0K	2
Ronfit forte capsules paracetamol BP 500 MG diclofenac sodium BP 50 mgcaffeine anhydrous BP 30 MG	$100.0K	2
Paraeffer cold (Pack size : 4 x 3)(paracetamol BP (325 MG), ascorbicacid BP 50MG, phenylephrine	$100.0K	2
Ronmax extra effer (Pack size : 4 x 3)(paracetamol BP 500 MG, diclofenac sodium BP 50MG, caffeine (anhydrous)	$100.0K	2
Ronfit forte (Pack size 10x2x10)(paracetamol BP 500MG, diclofenac sodium BP 50MG, caffeine (anhydrous) BP 30MG)	$98.8K	10

Roxin Ghana Limited imports 1,022 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Caffeine	Respiratory & OTC	$5.3M	390	4.9%	2
2	Mebendazole	Antimalarial & Antiparasitic	$190.8K	45	1.4%	13
3	Paracetamol Caffeine	Combination Drugs	$18.2K	4	1.3%	8

Roxin Ghana Limited imports 3 pharmaceutical products across 3 categories into Ghana totaling $5.5M.

Roxin Ghana Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Roxin Ghana Limited is a pharmaceutical importer and distributor based in Ghana, specializing in the procurement of finished pharmaceutical formulations from international suppliers. The company plays a pivotal role in the Ghanaian pharmaceutical supply chain by ensuring the availability of essential medications to meet the country's healthcare needs. While specific details about its parent company are not publicly disclosed, Roxin Ghana Limited's operations are integral to the distribution of pharmaceutical products within Ghana.

2Distribution Network

Roxin Ghana Limited's distribution network encompasses multiple warehouse locations strategically situated to facilitate efficient logistics operations across Ghana. The company's logistics capabilities are designed to ensure timely delivery of pharmaceutical products to various regions within the country, thereby supporting the healthcare infrastructure. While the primary focus is on domestic distribution, Roxin Ghana Limited's operations may extend to neighboring countries, depending on market demand and regulatory approvals.

3Industry Role

In Ghana's pharmaceutical supply chain, Roxin Ghana Limited functions as a primary wholesaler and distributor. The company imports finished pharmaceutical formulations from international suppliers, including India, and distributes these products to various stakeholders within the healthcare sector. This role is crucial in ensuring the consistent availability of medications across the country, thereby contributing to the overall health and well-being of the Ghanaian population.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Roxin Ghana Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Roxin Ghana Limited exhibits a high degree of supplier concentration, with 98% of its imports sourced from Ronak Exim Private Limited and 2% from Aculife Healthcare Private Limited. This single-source dependency may pose risks related to supply chain disruptions, such as production delays or quality control issues. The substantial volume of shipments from Ronak Exim Private Limited suggests a stable and long-term relationship; however, the limited number of suppliers could impact Roxin Ghana Limited's ability to diversify its product offerings or negotiate better terms.

2Supply Chain Resilience

The resilience of Roxin Ghana Limited's supply chain is closely tied to its reliance on a limited number of suppliers. The absence of backup suppliers increases vulnerability to potential disruptions from its primary suppliers. The company's focus on a narrow range of formulations may limit its ability to adapt to changing market demands or regulatory requirements. Additionally, the exposure to specific shipping routes and the regulatory compliance status of key suppliers are critical factors that influence the overall stability and resilience of the supply chain.

3Strategic Implications

Importing Pharmaceuticals into Ghana — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Ghana

1Regulatory Authority & Framework

The Food and Drugs Authority (FDA) is the national regulatory body responsible for overseeing the safety, efficacy, and quality of pharmaceutical products in Ghana. Established in 1997 under the Food and Drugs Law, 1992 (PNDCL 305B), the FDA operates under the Public Health Act, 2012 (Act 851), which mandates it to regulate the manufacture, importation, exportation, sale, and distribution of food, drugs, cosmetics, medical devices, and related products. The FDA's role is crucial in safeguarding public health by ensuring that all pharmaceutical products meet established standards before they reach the market. (moh.gov.gh)

2Import Licensing & GMP

Importers of pharmaceutical products into Ghana must obtain an import license from the FDA. This process involves registering the company with the FDA and obtaining an import permit, which is valid for one year. Additionally, the FDA requires that all imported pharmaceutical products be registered and comply with Good Manufacturing Practice (GMP) standards. Recognized GMP certifications include those from the European Union (EU GMP), the World Health Organization (WHO GMP), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers must ensure that their products meet these standards to gain approval for entry into the Ghanaian market. (fdaghana.gov.gh)

Roxin Ghana Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Roxin Ghana Limited's product strategy focuses on a narrow range of therapeutic categories, primarily respiratory and over-the-counter (OTC) medications, with minimal representation in antimalarial, antiparasitic, and combination drugs. This focus suggests a strategic alignment with prevalent health concerns in Ghana, such as respiratory illnesses and the need for accessible OTC treatments. The market demand for these products is likely driven by the high incidence of respiratory conditions and the preference for self-medication among consumers.

2Sourcing Profile

Roxin Ghana Limited's sourcing strategy is heavily concentrated on generic drug formulations, primarily sourced from India. The company's preference for finished pharmaceutical products indicates a focus on ready-to-market solutions that meet the regulatory standards of both India and Ghana. India's established pharmaceutical manufacturing capabilities and competitive pricing make it a strategic partner for Roxin Ghana Limited in fulfilling the country's pharmaceutical needs.

3Market Positioning

Based on its product mix, Roxin Ghana Limited serves the retail pharmacy segment of the Ghanaian market. The company's focus on respiratory and OTC medications aligns with the needs of retail pharmacies, which cater to consumers seeking accessible and affordable treatments for common health issues. By supplying these products, Roxin Ghana Limited supports the retail pharmacy sector in meeting consumer demand and enhancing public health outcomes.

Seller's Guide — How to Become a Supplier to Roxin Ghana Limited

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter Roxin Ghana Limited's supply chain by offering alternative products or formulations that meet the company's quality standards and regulatory requirements. Diversifying the supplier base could mitigate risks associated with single-source dependency and enhance the resilience of Roxin Ghana Limited's supply chain. Identifying gaps in the current sourcing strategy, such as the need for additional therapeutic categories or formulations, could provide avenues for new suppliers to establish partnerships.

2Requirements & Qualifications

Indian exporters seeking to supply Roxin Ghana Limited and the Ghanaian market must ensure that their products are registered with the FDA and comply with GMP standards recognized by the FDA. Additionally, products must meet the FDA's labeling requirements, including English language labeling with all necessary information. Exporters should also be prepared to provide certificates of analysis and comply with any additional testing or documentation requirements imposed by the FDA to facilitate the importation process.

3How to Approach

Frequently Asked Questions — Roxin Ghana Limited

What products does Roxin Ghana Limited import from India?

Roxin Ghana Limited imports 3 pharmaceutical products across 3 categories. Top imports: Caffeine ($5.3M), Mebendazole ($190.8K), Paracetamol Caffeine ($18.2K).

Who supplies pharmaceuticals to Roxin Ghana Limited from India?

Roxin Ghana Limited sources from 2 verified Indian suppliers. The primary supplier is Ronak Exim Private Limited (98.0% of imports, $15.6M).

What is Roxin Ghana Limited's total pharmaceutical import value?

Roxin Ghana Limited's total pharmaceutical import value from India is $5.5M, based on 439 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Roxin Ghana Limited focus on?

Roxin Ghana Limited imports across 3 categories. The largest: Respiratory & OTC (96.2%), Antimalarial & Antiparasitic (3.5%), Combination Drugs (0.3%).

Get Full Roxin Ghana Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.